QMD announced the launch of Nasogastric tubes in the portfolio of Degania Enteral Feeding Product. The material used for the manufacturing of these tubes adheres to the standards of ENFit for improving the safety of the patient, the designs are available for both babies and adults.
Securmed announced the collaboration with Delta Med Group to expand their company in the Italian and European markets. The agreement will lead to the development of better products of high quality.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5016
Published Date: Jun 14, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing cases of chronic diseases, rising prevalence of malnutrition, higher use of enteral feeding, and higher surgical procedures are the major factors driving the market growth.
The market size of nasogastric tube is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 â€“ 2035.
The major players in the market are Becton, Dickinson and Company, QMD, Angiplast Pvt. Ltd., Securmed, Vygon SAS, Medtronic, Andersen Products Ltd., Cardinal Health, Baihe Medical, and Poly Medicure Limited.
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by tube, patient group, indication, end user, and by region.
The dysphagia segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Cost and reimbursement policies, presence of alternatives, and risk of infections are estimated to be the growth hindering factors for the market expansion.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.